Results 31 to 40 of about 13,429 (224)

A System Based-Approach to Examine Host Response during Infection with Influenza A Virus Subtype H7N9 in Human and Avian Cells

open access: yesCells, 2020
Although the influenza A virus H7N9 subtype circulates within several avian species, it can also infect humans with a severe disease outcome. To better understand the biology of the H7N9 virus we examined the host response to infection in avian and human
Biruhalem Taye   +6 more
doaj   +1 more source

Weather variability and influenza A (H7N9) transmission in Shanghai, China: A Bayesian spatial analysis [PDF]

open access: yes, 2014
Background: A novel avian influenza A (H7N9) virus was first found in humans in Shanghai, and infected over 433 patients in China. To date, very little is known about the spatiotemporal variability or environmental drivers of the risk of H7N9 infection ...
Huang, Xiaodong   +8 more
core   +1 more source

Entry properties and entry inhibitors of a human H7N9 influenza virus. [PDF]

open access: yesPLoS ONE, 2014
The recently identified human infections with a novel avian influenza H7N9 virus in China raise important questions regarding possible risk to humans. However, the entry properties and tropism of this H7N9 virus were poorly understood.
Youhui Si   +10 more
doaj   +1 more source

Transcriptome Differences in Normal Human Bronchial Epithelial Cells in Response to Influenza A pdmH1N1 or H7N9 Virus Infection

open access: yesCells, 2022
Avian influenza A (H7N9) virus infections frequently lead to acute respiratory distress syndrome and death in humans. The emergence of H7N9 virus infections is a serious public health threat.
Tzu-Hsuan Hsieh   +6 more
doaj   +1 more source

H7N9 is a virus worth worrying about [PDF]

open access: yesNature, 2013
Warnings about the emergence of another influenza virus may elicit scepticism, but we should not be complacent, cautions Peter Horby.
Horby, P.   +13 more
openaire   +4 more sources

Nomogram for the Individualized Prediction of Survival Among Patients with H7N9 Infection

open access: yesRisk Management and Healthcare Policy, 2020
Qinglin Cheng,1,2,* Zhou Sun,1,* Gang Zhao,1,* Li Xie1,* 1Division of Infectious Diseases, Hangzhou Center for Disease Control and Prevention, Hangzhou 310021, People’s Republic of China; 2School of Public Health, Zhejiang Chinese Medical ...
Cheng Q, Sun Z, Zhao G, Xie L
doaj  

Saliva as a source of reagent to study human susceptibility to avian influenza H7N9 virus infection

open access: yesEmerging Microbes and Infections, 2018
Avian influenza H7N9 viruses are an important public health concern due to their high mortality rate and potentials for future pandemics. We investigated human susceptibility to H7N9 viruses using recombinant H7N9 hemagglutinin (HA) proteins as a probe ...
Ming Tan   +12 more
doaj   +1 more source

Risk assessment of the newly emerged H7N9 avian influenza viruses

open access: yesEmerging Microbes and Infections, 2023
Since the first human case in 2013, H7N9 avian influenza viruses (AIVs) have caused more than 1500 human infections with a mortality rate of approximately 40%.
Pengxiang Chang   +6 more
doaj   +1 more source

Virological, Serological, and Antiviral Studies in an Imported Human Case of Avian Influenza A(H7N9) Virus in Taiwan

open access: yes, 2017
We describe the clinical course and virological characteristics of the first H7N9 influenza case in a Taiwanese patient; this patient had detectable viruses in the airway for 2 weeks, during which time an oseltamivir resistance-associated R292K mutation ...
Lin, Pi-Han;Chao, Tai-Ling;Kuo, Shuenn-Wen;Wang, Jann-Tay;Hung, Chien-Ching;Lin, Huan-Chun;Yang, Zong-Yu;Ho, Shu-Yuan;Chang, Chun-Kai;Huang, Ming-Siang;Chen, Hui-Hou;Chen, Yee-Chun;Lai, Hong-Shiee;Chang, Sui-Yuan;Chang, Shan-Chwen;Yang, Pan-Chyr   +1 more
core   +1 more source

Allosteric Neutralization by Human H7N9 Antibodies

open access: yes, 2023
Abstract The avian influenza A virus H7N9 causes severe human infections with more than 30% fatality despite the use of neuraminidase inhibitors. Currently there is no H7N9-specific prevention or treatment for humans. From a 2013 H7N9 convalescent case occurred in Hong Kong, we isolated four H7 hemagglutinin (HA)-reactive monoclonal antibodies (
Xueling Wu   +12 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy